[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.

Using reliable techniques for detecting lymph node metastases (LNM) in oral squamous cell carcinoma (OSCC) is crucial for adequate neck treatment. Currently, palpation of the neck, computed tomography, magnetic resonance imaging, ultrasound-guided fine needle aspiration cytology and/or sentinel lymp...

Full description

Saved in:
Bibliographic Details
Main Authors: Roosmarijn S Tellman, Dominique N V Donders, Anne I J Arens, Koos Boeve, Adrienne H Brouwers, Simone E J Eerenstein, Sylvia L van Egmond, Thomas J W Klein Nulent, W Martin C Klop, Martin Lacko, Jochem A J van der Pol, Daphne D D Rietbergen, Robert P Takes, Joris Tim, Wouter V Vogel, Gerben J C Zwezerijnen, Bart de Keizer, Remco de Bree
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0325032
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849319454369906688
author Roosmarijn S Tellman
Dominique N V Donders
Anne I J Arens
Koos Boeve
Adrienne H Brouwers
Simone E J Eerenstein
Sylvia L van Egmond
Thomas J W Klein Nulent
W Martin C Klop
Martin Lacko
Jochem A J van der Pol
Daphne D D Rietbergen
Robert P Takes
Joris Tim
Wouter V Vogel
Gerben J C Zwezerijnen
Bart de Keizer
Remco de Bree
author_facet Roosmarijn S Tellman
Dominique N V Donders
Anne I J Arens
Koos Boeve
Adrienne H Brouwers
Simone E J Eerenstein
Sylvia L van Egmond
Thomas J W Klein Nulent
W Martin C Klop
Martin Lacko
Jochem A J van der Pol
Daphne D D Rietbergen
Robert P Takes
Joris Tim
Wouter V Vogel
Gerben J C Zwezerijnen
Bart de Keizer
Remco de Bree
author_sort Roosmarijn S Tellman
collection DOAJ
description Using reliable techniques for detecting lymph node metastases (LNM) in oral squamous cell carcinoma (OSCC) is crucial for adequate neck treatment. Currently, palpation of the neck, computed tomography, magnetic resonance imaging, ultrasound-guided fine needle aspiration cytology and/or sentinel lymph node biopsy (SLNB) are used to stage the neck in early-stage OSCC. SLNB is a reliable diagnostic technique to detect occult LNM. However, management of the neck with SLNB has its limitations. First of all, SLNB is an invasive procedure with associated morbidity and approximately 20-30% of patients require a subsequent neck dissection. Moreover, performing a subsequent neck dissection is more complex than elective neck dissection, and carries a higher risk of complications. Therefore, it is important to improve patient selection for SLNB. Fluor-18-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) has shown promising results for LNM detection. The aim of the PETN0 study, a prospective Dutch multicenter cohort study (registration number NL83442.041.22), is to reduce the need for SLNB by developing scoring criteria for [18F]FDG PET/CT with a high positive predictive value (PPV) in patients with early-stage OSCC. Developing scoring criteria for a high PPV can reduce SLNBs and second-stage neck dissections by performing a neck dissection together with resection of the primary tumor in patients with predicted LNM. When focused on high PPV the sensitivity will probably be lower, but missed LNM will be detected by SLNB when performed after negative [18F]FDG PET/CT. Patients (n = 159) with cT1-3N0 OSCC (8th TNM edition; only when T3 is assessed based on tumor dimensions of >2 and ≤4 cm, with DOI > 10 mm), candidate for transoral excision and SLNB, are included in the study. [18F]FDG PET/CT will be conducted within a maximum of three weeks before SLNB. A cost-effectiveness analysis will also be performed, together with quality of life assessment using questionnaires.
format Article
id doaj-art-987c507960da4aa48c05813e4d9f1ff7
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-987c507960da4aa48c05813e4d9f1ff72025-08-20T03:50:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032503210.1371/journal.pone.0325032[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.Roosmarijn S TellmanDominique N V DondersAnne I J ArensKoos BoeveAdrienne H BrouwersSimone E J EerensteinSylvia L van EgmondThomas J W Klein NulentW Martin C KlopMartin LackoJochem A J van der PolDaphne D D RietbergenRobert P TakesJoris TimWouter V VogelGerben J C ZwezerijnenBart de KeizerRemco de BreeUsing reliable techniques for detecting lymph node metastases (LNM) in oral squamous cell carcinoma (OSCC) is crucial for adequate neck treatment. Currently, palpation of the neck, computed tomography, magnetic resonance imaging, ultrasound-guided fine needle aspiration cytology and/or sentinel lymph node biopsy (SLNB) are used to stage the neck in early-stage OSCC. SLNB is a reliable diagnostic technique to detect occult LNM. However, management of the neck with SLNB has its limitations. First of all, SLNB is an invasive procedure with associated morbidity and approximately 20-30% of patients require a subsequent neck dissection. Moreover, performing a subsequent neck dissection is more complex than elective neck dissection, and carries a higher risk of complications. Therefore, it is important to improve patient selection for SLNB. Fluor-18-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) has shown promising results for LNM detection. The aim of the PETN0 study, a prospective Dutch multicenter cohort study (registration number NL83442.041.22), is to reduce the need for SLNB by developing scoring criteria for [18F]FDG PET/CT with a high positive predictive value (PPV) in patients with early-stage OSCC. Developing scoring criteria for a high PPV can reduce SLNBs and second-stage neck dissections by performing a neck dissection together with resection of the primary tumor in patients with predicted LNM. When focused on high PPV the sensitivity will probably be lower, but missed LNM will be detected by SLNB when performed after negative [18F]FDG PET/CT. Patients (n = 159) with cT1-3N0 OSCC (8th TNM edition; only when T3 is assessed based on tumor dimensions of >2 and ≤4 cm, with DOI > 10 mm), candidate for transoral excision and SLNB, are included in the study. [18F]FDG PET/CT will be conducted within a maximum of three weeks before SLNB. A cost-effectiveness analysis will also be performed, together with quality of life assessment using questionnaires.https://doi.org/10.1371/journal.pone.0325032
spellingShingle Roosmarijn S Tellman
Dominique N V Donders
Anne I J Arens
Koos Boeve
Adrienne H Brouwers
Simone E J Eerenstein
Sylvia L van Egmond
Thomas J W Klein Nulent
W Martin C Klop
Martin Lacko
Jochem A J van der Pol
Daphne D D Rietbergen
Robert P Takes
Joris Tim
Wouter V Vogel
Gerben J C Zwezerijnen
Bart de Keizer
Remco de Bree
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
PLoS ONE
title [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
title_full [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
title_fullStr [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
title_full_unstemmed [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
title_short [18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.
title_sort 18f fdg pet ct to reduce the need for sentinel lymph node biopsy in early stage oral cancer petn0 study protocol
url https://doi.org/10.1371/journal.pone.0325032
work_keys_str_mv AT roosmarijnstellman 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT dominiquenvdonders 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT anneijarens 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT koosboeve 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT adriennehbrouwers 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT simoneejeerenstein 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT sylvialvanegmond 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT thomasjwkleinnulent 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT wmartincklop 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT martinlacko 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT jochemajvanderpol 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT daphneddrietbergen 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT robertptakes 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT joristim 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT woutervvogel 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT gerbenjczwezerijnen 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT bartdekeizer 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol
AT remcodebree 18ffdgpetcttoreducetheneedforsentinellymphnodebiopsyinearlystageoralcancerpetn0studyprotocol